These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15738593)

  • 1. [Stage IV Wilms' tumour -- analysis of treatment results, according to the SIOP 93-01 protocol, at the Medical University of Gdańsk].
    Stefanowicz J; Sierota D; Połczyńska K; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):193-6. PubMed ID: 15738593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal neoplasms in children].
    Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
    Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
    Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relapses in children with nephroblastoma--a single centre experience].
    Stefanowicz J; Sierota D; Połczyńska K; Adamkiewicz-Drozyńska E; Szołkiewicz A; Bień E; Stachowicz-Stencel T; Komasara L; Czauderna P; Balcerska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):523-30. PubMed ID: 16719165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late side-effects of treatment in patients with nephroblastoma].
    Sierota D; Stefanowicz J; Aleszewicz-Baranowska J; Birkholz D; Kosiak W; Adamkiewicz-Drozyńska E; Balcerska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):517-22. PubMed ID: 16719164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of chemotherapy in treatment of nephroblastoma in children. Report of the Polish Pediatric Group re. treatments of solid tumors].
    Sawicz-Birkowska K; Czernik J; Godziński J; Bagłaj M; Balcerska A; Daszkiewicz P; Dembowska B; Drozyńska U; Kantorowicz S; Kazanowska B; Kaski K; Madziara W; Perek D; Skotnicka G; Rokicka-Milewska R; Radwańska U; Wysocki M; Apoznański W
    Pol Merkur Lekarski; 1998 Mar; 4(21):134-6. PubMed ID: 9640063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
    de Kraker J; Graf N; van Tinteren H; Pein F; Sandstedt B; Godzinski J; Tournade MF;
    Lancet; 2004 Oct 2-8; 364(9441):1229-35. PubMed ID: 15464183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study].
    Ludwig R; Weirich A; Pötter R; Harms D; Bürger D; Michaelis J; Erttmann R; Weinel P; Haas RJ; Ritter J
    Klin Padiatr; 1992; 204(4):204-13. PubMed ID: 1325574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
    J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors in relapses of Wilms' tumor--results for the Polish Pediatric Solid Tumors Study Group.
    Niedzielska E; Bronowicki K; Pietras W; Sawicz-Birkowska K; Trybucka K; Rąpała M; Karpińska-Derda I; Kurylak A; Marciniak-Stępak P; Panasiuk A; Nurzyńska-Flak J; Peregud-Pogorzelski J; Pietrys D; Rurańska I; Sobol G; Stefanowicz J; Szymik-Kantorowicz S; Zubowska M; Godziński J
    Adv Clin Exp Med; 2014; 23(6):925-31. PubMed ID: 25618119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy.
    Maes P; Delemarre J; de Kraker J; Ninane J
    Eur J Cancer; 1999 Sep; 35(9):1356-60. PubMed ID: 10658527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bilateral Wilms' tumour. Results of treatment in 29 children].
    Sawicz-Birkowska K; Apoznanski W; Dembowska-Bagińska B; Balcerska A; Szymik-Kantorowicz S; Perek D; Wachowiak J; Wysocki M; Klepacka T; Zaleska-Dorobisz U
    Med Wieku Rozwoj; 2003; 7(3):369-80. PubMed ID: 14963344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.